Individuals with gastroesophageal reflux disease have a higher prevalence of psychiatric disorders, which calls for a multidisciplinary approach to treatment.

We speak with prominent alopecia researchers and experts to gain insights into the burden associated with hair loss as well as standard and new treatment options for alopecia.

HIPAA protects patients from unauthorized disclosure of personal information by covered entities such as medical practices and hospitals, but out from under the HIPAA umbrella, patients are mostly on their own, according to the authors of a recent report.

Jim Anderson, MPAS, PA-C, wonders if SAMHSA will make the methadone take-home flexibility program permanent.

Joseph D. Dougherty, PhD discusses genetic compounds’ ability to clear amyloid-β from the brain in patients with Alzheimer disease.

Studies from Psych Congress 2022 show the efficacy of ketamine and psilocybin in reducing symptoms of treatment-resistant depression.

GAPNA reviews studies on the links between dementia and cardiometabolic multimorbidity, atrial cardiopathy, and cardiovascular disease in midlife.

Drs Yuki Sakai, MD, PhD, and Saori C Tanaka, PhD, discuss using computational theory and experimental validation to identify the underlying mechanism of obsessive-compulsive disorder.

Aduhelm, a monoclonal antibody that targets amyloid-beta, is covered under Medicare for beneficiaries enrolled in clinical trials.

A 22-year-old man presents to the outpatient office following an overdose of antihistamines and alcohol. He was feeling overwhelmed trying to transition to in-person classes at the university after taking online classes during the COVID-19 lockdown.